Professor, IMU University, Malaysia 🌟
Dr. Chun-Wai Mai, a highly accomplished researcher and professor from Malaysia, is devoted to understanding the mechanisms behind tumorigenesis and metastasis. With a vision to uncover the origins of cancer, Dr. Mai aims to enhance clinical prognosis and improve patient outcomes. Over the years, he has held pivotal academic and research roles, contributing significantly to oncology, stem cell biology, genomics, and drug discovery. His work embodies a commitment to advancing medical science and tackling cancer at its roots.
Profile
Orcid
Education 🎓
Dr. Chun-Wai Mai earned his PhD in Pharmaceutical Sciences (2010–2014) and Bachelor of Pharmacy degree (2005–2009) from the International Medical University (IMU) in Kuala Lumpur, Malaysia. His strong academic foundation has fueled his impactful contributions to cancer research and drug development.
Experience 🧑🔬
Dr. Mai is currently a Professor at the Centre for Cancer and Stem Cell Research, International Medical University. He previously served as an Associate Professor at UCSI University (2022–2025), a Postdoctoral Fellow at Shanghai Jiao Tong University School of Medicine (2020–2022), and as a Senior Lecturer (2018–2020) and Lecturer (2010–2018) at IMU. His extensive academic journey reflects his dedication to education and research excellence.
Research Interests 🔬
Dr. Mai’s research focuses on tumorigenesis, metastasis, stem cells, and drug discovery, with a keen interest in genomics and anticancer mechanisms. He is driven by the goal of developing targeted therapies to combat cancer and improve patient outcomes, particularly in addressing the challenges of drug resistance and cancer progression.
Awards 🏆
Dr. Mai is a distinguished member of esteemed organizations, including the European Association for Cancer Research and the Royal Society of Chemistry. His groundbreaking research has earned recognition in oncology and stem cell therapy, marking him as a leader in his field.
Publications 📚
Phytochemical Analysis and Biological Activities of Flavonoids and Anthraquinones from Cassia alata (Linnaeus) Roxburgh (Plants, 2025): 10.3390/plants14030362
Scoping Review of Enablers and Challenges of Implementing Pharmacogenomics Testing in Primary Care Settings (BMJ Open, 2024): 10.1136/bmjopen-2024-087064
Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities (Sci, 2024): 10.3390/sci6040068
Revolutionizing Treatment for Nasopharyngeal Cancer with Stem Cell and Genetically Engineered Therapies (Frontiers in Immunology, 2024): 10.3389/fimmu.2024.1484535
Molecular Mechanism of Tocotrienol-Mediated Anticancer Properties: Systematic Review (Nutrients, 2023): 10.3390/nu15081854
Conclusion
Dr. Chun-Wai Mai’s outstanding academic background, impactful research contributions, and leadership in oncology and drug discovery make him an excellent candidate for the Best Researcher Award. His focus on advancing cancer therapies aligns with the award’s vision of recognizing transformative scientific contributions. By further showcasing patents, grants, and global collaborations, Dr. Mai’s profile could achieve even greater prominence in the scientific community.